Matthias Hommel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Matthias Hommel has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Evgenij V. Potapov
German Heart Center Berlin
3 shared publications Maria Deja
Department of Anesthesiology and Intensive Care Medicine, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Campus Mitte, Berlin, Germany
3 shared publications- Steffen Weber-Carstens
Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany
3 shared publications Volkmar Falk
3 shared publicationsAxel Unbehaun
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
2 shared publications- Axel Unbehaun
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany (D.S., H.H., A.U.).
2 shared publications
Latest Publications
- Open Access
Enhanced Recovery After Cardiac Surgery for Minimally Invasive Valve Surgery: A Systematic Review of Key Elements and Advancements
Background and Objectives: Minimally invasive valve surgery (MIVS), integrated within enhanced recovery after surgery (ERAS) programs, is a pivotal advancement in modern cardiac surgery, aiming to reduce perioperative morbidity and accelerate recovery. This systematic review analyzes the integration of ERAS components into MIVS programs and evaluates their impact on perioperative outcomes and patient recovery. Materials and Methods: A systematic search of PubMed/Medline, conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, identified studies on ERAS in MIVS patients. Coronary and robotic surgery were excluded to prioritize widely adopted minimally invasive valve methods. Studies were included if they applied ERAS protocols primarily to MIVS patients, with at least five participants per study. Data on study characteristics, ERAS components, and patient outcomes were extracted for analysis. Results: Eight studies met the inclusion criteria, encompassing 1287 MIVS patients (842 ERAS, 445 non-ERAS). ERAS protocols in MIVS were heterogeneous, with studies implementing 9 to 18 of 24 ERAS measures recommended by the ERAS consensus guideline, reflecting local hospital practices and resource availability. Common elements include patient education and multidisciplinary teams, early extubation followed by mobilization, multimodal opioid-sparing pain management, and timely removal of invasive lines. Despite protocol variability, these programs were associated with reduced morbidity, shorter hospital stays (intensive care unit-stay reductions of 4–20 h to complete omission, and total length of stay by ≥1 day), and cost savings of up to EUR 1909.8 per patient without compromising safety. Conclusions: ERAS protocols and MIVS synergistically enhance recovery and reduce the length of hospital stay. Standardizing ERAS protocols for MVS could amplify these benefits and broaden adoption.
Open AccessEnhanced Recovery After Cardiac Surgery for Minimally Invasive Valve Surgery: A Systematic Review of Key Elements and Advancements
Background and Objectives: Minimally invasive valve surgery (MIVS), integrated within enhanced recovery after surgery (ERAS) programs, is a pivotal advancement in modern cardiac surgery, aiming to reduce perioperative morbidity and accelerate recovery. This systematic review analyzes the integration of ERAS components into MIVS programs and evaluates their impact on perioperative outcomes and patient recovery. Materials and Methods: A systematic search of PubMed/Medline, conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, identified studies on ERAS in MIVS patients. Coronary and robotic surgery were excluded to prioritize widely adopted minimally invasive valve methods. Studies were included if they applied ERAS protocols primarily to MIVS patients, with at least five participants per study. Data on study characteristics, ERAS components, and patient outcomes were extracted for analysis. Results: Eight studies met the inclusion criteria, encompassing 1287 MIVS patients (842 ERAS, 445 non-ERAS). ERAS protocols in MIVS were heterogeneous, with studies implementing 9 to 18 of 24 ERAS measures recommended by the ERAS consensus guideline, reflecting local hospital practices and resource availability. Common elements include patient education and multidisciplinary teams, early extubation followed by mobilization, multimodal opioid-sparing pain management, and timely removal of invasive lines. Despite protocol variability, these programs were associated with reduced morbidity, shorter hospital stays (intensive care unit-stay reductions of 4–20 h to complete omission, and total length of stay by ≥1 day), and cost savings of up to EUR 1909.8 per patient without compromising safety. Conclusions: ERAS protocols and MIVS synergistically enhance recovery and reduce the length of hospital stay. Standardizing ERAS protocols for MVS could amplify these benefits and broaden adoption.
- Open Access
- 30 December 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 44 (6) , 880-891
Impact of complications on survival outcomes in different temporary mechanical circulatory support techniques: A large retrospective cohort study of cardiac surgical and nonsurgical patients
- 30 December 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 44 (6) , 880-891
Open AccessImpact of complications on survival outcomes in different temporary mechanical circulatory support techniques: A large retrospective cohort study of cardiac surgical and nonsurgical patients
- 1 January 2024
- Published by Georg Thieme Verlag KG
Therapieprinzipien in der Intensivmedizin
- 15 February 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (11) , 1332-1338
Interventional Procedures for Left Ventricular Assist Device-Associated Complications
As patients on long-term left ventricular assist device (LVAD) face a substantial risk for open cardiac reoperation, interventional treatment approaches are becoming increasingly important in this population. We evaluated data of 871 patients who were on LVAD support between January 1, 2016 and December 1, 2020. Interventional treatments for LVAD-associated complications were performed in 76 patients. Seventeen patients underwent transcatheter aortic valve replacements (TAVR) and 61 patients underwent outflow graft interventions (OGI). TAVR improved symptoms in patients with severe symptomatic aortic regurgitation. Postinterventional complications included aggravation of preexisting right heart failure (RHF), third-degree atrioventricular block, and intrapump thrombosis (in 3 [16.7%], 2 [11.1%], and 1 [5.6%] patients, respectively). In outflow graft obstructions, OGI led to recovery of LVAD flow (p < 0.001), unloading of the left ventricle (p = 0.004), decrease of aortic valve opening time (p = 0.010), and improvement of right heart function (p < 0.001). Complications included bleeding, RHF, and others (in 9 [10.8%], 5 [6.0%], and 5 [6.0%] patients, respectively). Eight (9.6%) patients died within the hospital stay after OGI, including mortality secondary to prolonged cardiogenic shock. In conclusion, interventional procedures are a feasible and safe treatment modality for LVAD-associated complications.
- 15 February 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (11) , 1332-1338
Interventional Procedures for Left Ventricular Assist Device-Associated Complications
As patients on long-term left ventricular assist device (LVAD) face a substantial risk for open cardiac reoperation, interventional treatment approaches are becoming increasingly important in this population. We evaluated data of 871 patients who were on LVAD support between January 1, 2016 and December 1, 2020. Interventional treatments for LVAD-associated complications were performed in 76 patients. Seventeen patients underwent transcatheter aortic valve replacements (TAVR) and 61 patients underwent outflow graft interventions (OGI). TAVR improved symptoms in patients with severe symptomatic aortic regurgitation. Postinterventional complications included aggravation of preexisting right heart failure (RHF), third-degree atrioventricular block, and intrapump thrombosis (in 3 [16.7%], 2 [11.1%], and 1 [5.6%] patients, respectively). In outflow graft obstructions, OGI led to recovery of LVAD flow (p < 0.001), unloading of the left ventricle (p = 0.004), decrease of aortic valve opening time (p = 0.010), and improvement of right heart function (p < 0.001). Complications included bleeding, RHF, and others (in 9 [10.8%], 5 [6.0%], and 5 [6.0%] patients, respectively). Eight (9.6%) patients died within the hospital stay after OGI, including mortality secondary to prolonged cardiogenic shock. In conclusion, interventional procedures are a feasible and safe treatment modality for LVAD-associated complications.
- 1 January 2022
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 70 (S 01) , S1-S61
Transcatheter Aortic Valve Implantation for Severe Aortic Regurgitation in Patients with Left Ventricular Assist Device Support
Background: Approximately 15% of patients on left ventricular assist device (LVAD) support develop severe aortic regurgitation (AR). Since patients on LVAD support are considered at high risk for reoperation, the interventional approach is becoming increasingly important in this patient cohort. Method: We conducted a retrospective analysis to evaluate the outcomes of patients on LVAD support, who underwent transcatheter aortic valve implantation (TAVI) at our institution between January 1, 2016, and December 1, 2020. Results: During the investigational period, 18 TAVI were performed in LVAD patients at our institution. Mean age was 62.4 (±9.6) years and 72.2% were male. Before LVAD implantation, no or mild AR was pre-existing. The time from LVAD implantation to severe AR ranged from 0.5 to 9.5 years. Seventeen (94.4%) interventions were performed via femoral access. In total 18 (78.3%) balloon-expandable valves and 5 (21.7%) self-expandable valves were implanted. Six (35.3%) patients showed trans-stent leak after valve implantation and were treated with valve-in-valve implantation. In five patients the implantation was performed during the same procedure, in one patient 69 days after index procedure. Overall, technical success according to the Valve Academic Research Consortium 3 (VARC-3) was achieved in 72.2% cases. 33.3% of patients were directly transferred from the recovery room to the normal ward; 50.0% of patients spent 1 or 2 days in the intensive care unit. The median length of hospital stay was 7.5 (4.5–20.75) days. Pre intervention, all patients presented with symptoms of HF of functional New York Heart Association class 3 or 4. After TAVI 77.8% of patients had no or only mild symptoms. In two patients minor vascular and access-related complications (as determined by VARC-3) occurred: one patient required endovascular stenting of the common femoral artery and the other conservative treatment of an arteriovenous fistula. Two patients suffered from third-degree atrioventricular block. One patient developed LVAD intra-pump thrombosis. No patient suffered from VARC type ≥ 2 bleeding. Post-TAVI right heart failure with need for inotropic support was seen in three patients, of which one died within the hospital stay. Another patient died due to sepsis of unknown origin in an external hospital. This resulted in an all-cause mortality of 10.2% at 30 days. Conclusion: TAVI is a safe and feasible way to treat severe aortic regurgitation in patients on LVAD support. Publication Date: 03 February 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 January 2022
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 70 (S 01) , S1-S61
Transcatheter Aortic Valve Implantation for Severe Aortic Regurgitation in Patients with Left Ventricular Assist Device Support
Background: Approximately 15% of patients on left ventricular assist device (LVAD) support develop severe aortic regurgitation (AR). Since patients on LVAD support are considered at high risk for reoperation, the interventional approach is becoming increasingly important in this patient cohort. Method: We conducted a retrospective analysis to evaluate the outcomes of patients on LVAD support, who underwent transcatheter aortic valve implantation (TAVI) at our institution between January 1, 2016, and December 1, 2020. Results: During the investigational period, 18 TAVI were performed in LVAD patients at our institution. Mean age was 62.4 (±9.6) years and 72.2% were male. Before LVAD implantation, no or mild AR was pre-existing. The time from LVAD implantation to severe AR ranged from 0.5 to 9.5 years. Seventeen (94.4%) interventions were performed via femoral access. In total 18 (78.3%) balloon-expandable valves and 5 (21.7%) self-expandable valves were implanted. Six (35.3%) patients showed trans-stent leak after valve implantation and were treated with valve-in-valve implantation. In five patients the implantation was performed during the same procedure, in one patient 69 days after index procedure. Overall, technical success according to the Valve Academic Research Consortium 3 (VARC-3) was achieved in 72.2% cases. 33.3% of patients were directly transferred from the recovery room to the normal ward; 50.0% of patients spent 1 or 2 days in the intensive care unit. The median length of hospital stay was 7.5 (4.5–20.75) days. Pre intervention, all patients presented with symptoms of HF of functional New York Heart Association class 3 or 4. After TAVI 77.8% of patients had no or only mild symptoms. In two patients minor vascular and access-related complications (as determined by VARC-3) occurred: one patient required endovascular stenting of the common femoral artery and the other conservative treatment of an arteriovenous fistula. Two patients suffered from third-degree atrioventricular block. One patient developed LVAD intra-pump thrombosis. No patient suffered from VARC type ≥ 2 bleeding. Post-TAVI right heart failure with need for inotropic support was seen in three patients, of which one died within the hospital stay. Another patient died due to sepsis of unknown origin in an external hospital. This resulted in an all-cause mortality of 10.2% at 30 days. Conclusion: TAVI is a safe and feasible way to treat severe aortic regurgitation in patients on LVAD support. Publication Date: 03 February 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 28 August 2020
- Published by Wiley
Reply to Del Giglio, Tamagnini, Biondi and Di Mauro
LETTER TO THE EDITOR RESPONSEWe thank Dr. Del Giglio et al. for their comments. As it was stated in our paper1, our primary goal was to describe our approach and procedural details to MIAVR by way of RALT. For further reading we would also like to draw attention to our video tutorial regarding RALT-MIAVR2. Nevertheless, we would like to congratulate Dr. Del Giglio and his colleagues for their significant contribution to the field of minimally invasive aortic valve treatment3 4 56.We completely agree with Dr. Del Giglio et al. that our statement regarding preoperative CT-scanning being mandatory is somehow misleading. However, other colleagues also consider a preoperative CT scan obligatory for RALT-MIAVR7 providing important additional information over TEE8. Three-dimensional reconstructed multidetector CT images allow virtual planning of the exposure leading to a reduced ischemia time and a reduced conversion rate9. It has also been shown that systematic preoperative CT screening in MIMVS is associated with lower risk of postoperative stroke and a trend towards lower operative mortality10. Although we agree with Dr. Del Giglio et al. that CT assessment is helpful at the beginning, it remains accommodating throughout the complete learning curve and thereafter. Andre Plass et al.11 wrote that preoperative planning with multi-slice CT leads to an improved mental preparation and to an efficient and accurate surgical strategy including the choice of the optimal ICS. In their Letter to the Editor , Dr. Del Giglio et al. wrote that surgical access site selection does not require a CT scan, that the third ICS is the right one in most cases and that the surgeon could easily change to the second ICS from the same skin incision. We agree that changing ICS is easily possible, yet it also means added surgical damage and this should be avoided whenever possible. An automated method determining the closest ICS to the STJ as the optimal incision location for MIAVR has already been introduced12. A novel MIAVR tool that combines 3D imaging with quantitative planning measures has also been described13. The access angle is strongly associated with procedure complexity13 and with CPB time, x-clamping time and access difficulty13. Moodley et al.14 reported that mandatory CT-screening of the chest, abdomen and pelvis revealed significant subclinical aorto-iliac atherosclerosis resulting in a change in surgical approach in 21% of asymptomatic or mildly symptomatic patients scheduled for MIMVS (Figures 1 through 3). Regarding the interpreting and reconstructing of CT scans we agree with Dr. Del Giglio et al. that this means technological skills, time and financial resources. But with transcatheter cardiac procedures becoming more popular, it is important for the society of surgeons to master all aspects of case planning, which not only includes analysis and measurement but also the reconstruction of CT scans. As pointed out by Dr. Del Giglio et al. MIAVR has to reproduce the gold-standard conventional procedure in terms of safety, effectiveness and especially operative times through a respectful approach; yet in our opinion, preoperative non-invasive CTA screening in every patient scheduled for a RALT-MIAVR procedure remains crucial.In view of truly MIAVR, we believe that arterial and venous central cannulation both at the same time through the same incision does not reduce surgical trauma and could lead to central working port obstruction or significant narrowing. We believe that peripheral cannulation of the femoral vasculature is as safe and reproducible as central cannulation if the individualized anatomical characteristics allow for it. When carrying out percutaneous femoral arterial cannulation, we never perform a blind puncture of the femoral vessels. We prefer to have zoomed-in snapshots from our reconstructed CT scans on display in the OR to accurately puncture the CFA as displayed in figures 1 and 2 for example. Data set published by Eugene A. Grossi et al.15, suggest that if in older patients a femoral perfusion technique is chosen, preoperative evaluation of the aorta and distal vasculature would demonstrate that a given patient would not be at increased neurological risk15. This would include CTA of the aorta with runoff and TEE evaluation of the descending aorta15. They also published that RAP is associated with an increased risk of stroke in patients with severe PVD and should be reserved for selected patients without significant atherosclerosis. Such a thoughtful screening approach has been used also by Murphy and associates16 in robotic mitral valve surgery for example15. M. Murzi et al.17 were able to show that the use of RAP in MIMVS was associated with a higher incidence of neurological complications in older patients (>70 years old) with atherosclerotic burden compared with AAP. Still, their study had several limitations as it was based on a retrospective analysis of patients undergoing consecutive MIMVS over a 12-year period and potential bias might have been present17. The observational retrospective analysis of K. Bedeir et al.18 proved that femoral artery cannulation may be associated with increased stroke rates in isolated mitral valve surgery and that antegrade arterial cannulation (direct aortic or axillary cannulation (figure 2)) may be preferable in MIAVR. However, their consensus was that these preliminary data should trigger a larger-scale randomized prospective trial to confirm or refute these findings18.In pursuance of reducing hemolysis during CPB19, body temperature is maintained at around 34°C and DO2-guidance (goal-directed-perfusion). This is also helpful in regard to optimal venous drainage as it allows the surgeon1,2, to safely reduce the calculated pump flow. Furthermore, we augment venous drainage with the use of vacuum assistance (−20 to −35 mmHg) to decompress the right heart1. On one hand, R.K. Mathews et al.20 were not able to show a...
- 28 August 2020
- Published by Wiley
Open AccessReply to Del Giglio, Tamagnini, Biondi and Di Mauro
LETTER TO THE EDITOR RESPONSEWe thank Dr. Del Giglio et al. for their comments. As it was stated in our paper1, our primary goal was to describe our approach and procedural details to MIAVR by way of RALT. For further reading we would also like to draw attention to our video tutorial regarding RALT-MIAVR2. Nevertheless, we would like to congratulate Dr. Del Giglio and his colleagues for their significant contribution to the field of minimally invasive aortic valve treatment3 4 56.We completely agree with Dr. Del Giglio et al. that our statement regarding preoperative CT-scanning being mandatory is somehow misleading. However, other colleagues also consider a preoperative CT scan obligatory for RALT-MIAVR7 providing important additional information over TEE8. Three-dimensional reconstructed multidetector CT images allow virtual planning of the exposure leading to a reduced ischemia time and a reduced conversion rate9. It has also been shown that systematic preoperative CT screening in MIMVS is associated with lower risk of postoperative stroke and a trend towards lower operative mortality10. Although we agree with Dr. Del Giglio et al. that CT assessment is helpful at the beginning, it remains accommodating throughout the complete learning curve and thereafter. Andre Plass et al.11 wrote that preoperative planning with multi-slice CT leads to an improved mental preparation and to an efficient and accurate surgical strategy including the choice of the optimal ICS. In their Letter to the Editor , Dr. Del Giglio et al. wrote that surgical access site selection does not require a CT scan, that the third ICS is the right one in most cases and that the surgeon could easily change to the second ICS from the same skin incision. We agree that changing ICS is easily possible, yet it also means added surgical damage and this should be avoided whenever possible. An automated method determining the closest ICS to the STJ as the optimal incision location for MIAVR has already been introduced12. A novel MIAVR tool that combines 3D imaging with quantitative planning measures has also been described13. The access angle is strongly associated with procedure complexity13 and with CPB time, x-clamping time and access difficulty13. Moodley et al.14 reported that mandatory CT-screening of the chest, abdomen and pelvis revealed significant subclinical aorto-iliac atherosclerosis resulting in a change in surgical approach in 21% of asymptomatic or mildly symptomatic patients scheduled for MIMVS (Figures 1 through 3). Regarding the interpreting and reconstructing of CT scans we agree with Dr. Del Giglio et al. that this means technological skills, time and financial resources. But with transcatheter cardiac procedures becoming more popular, it is important for the society of surgeons to master all aspects of case planning, which not only includes analysis and measurement but also the reconstruction of CT scans. As pointed out by Dr. Del Giglio et al. MIAVR has to reproduce the gold-standard conventional procedure in terms of safety, effectiveness and especially operative times through a respectful approach; yet in our opinion, preoperative non-invasive CTA screening in every patient scheduled for a RALT-MIAVR procedure remains crucial.In view of truly MIAVR, we believe that arterial and venous central cannulation both at the same time through the same incision does not reduce surgical trauma and could lead to central working port obstruction or significant narrowing. We believe that peripheral cannulation of the femoral vasculature is as safe and reproducible as central cannulation if the individualized anatomical characteristics allow for it. When carrying out percutaneous femoral arterial cannulation, we never perform a blind puncture of the femoral vessels. We prefer to have zoomed-in snapshots from our reconstructed CT scans on display in the OR to accurately puncture the CFA as displayed in figures 1 and 2 for example. Data set published by Eugene A. Grossi et al.15, suggest that if in older patients a femoral perfusion technique is chosen, preoperative evaluation of the aorta and distal vasculature would demonstrate that a given patient would not be at increased neurological risk15. This would include CTA of the aorta with runoff and TEE evaluation of the descending aorta15. They also published that RAP is associated with an increased risk of stroke in patients with severe PVD and should be reserved for selected patients without significant atherosclerosis. Such a thoughtful screening approach has been used also by Murphy and associates16 in robotic mitral valve surgery for example15. M. Murzi et al.17 were able to show that the use of RAP in MIMVS was associated with a higher incidence of neurological complications in older patients (>70 years old) with atherosclerotic burden compared with AAP. Still, their study had several limitations as it was based on a retrospective analysis of patients undergoing consecutive MIMVS over a 12-year period and potential bias might have been present17. The observational retrospective analysis of K. Bedeir et al.18 proved that femoral artery cannulation may be associated with increased stroke rates in isolated mitral valve surgery and that antegrade arterial cannulation (direct aortic or axillary cannulation (figure 2)) may be preferable in MIAVR. However, their consensus was that these preliminary data should trigger a larger-scale randomized prospective trial to confirm or refute these findings18.In pursuance of reducing hemolysis during CPB19, body temperature is maintained at around 34°C and DO2-guidance (goal-directed-perfusion). This is also helpful in regard to optimal venous drainage as it allows the surgeon1,2, to safely reduce the calculated pump flow. Furthermore, we augment venous drainage with the use of vacuum assistance (−20 to −35 mmHg) to decompress the right heart1. On one hand, R.K. Mathews et al.20 were not able to show a...
- Open Access
- 31 July 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (6) , 887-891
Incidence and echocardiographic predictors of early postoperative right ventricular dysfunction following left ventricular assist implantation in paediatric patients
Left ventricular assist device implantation is an established therapy for paediatric patients with end-stage heart failure. Early right ventricular dysfunction (RVD) after implantation still remains a challenge in the postoperative period. This study sought to determine the incidence of RVD and to identify echocardiographic predictors of RVD in paediatric patients, as well describing associated clinical outcome. Prospectively collected preoperative echocardiographic, haemodynamic, demographic and biochemical data from 48 patients scheduled for left ventricular assist device implantation were evaluated. Incidence of high central venous pressure, decreased central venous saturation, high inotropic support requirements or need for mechanical support of the right ventricle during the first 48 h after implantation were used to define RVD. Echocardiographic assessments of right ventricular geometry, function using linear dimensions, areas and tricuspid annular plane systolic excursion (TAPSE) were performed preoperatively and the relative relationships between these parameters were evaluated. We included 48 consecutive paediatric patients (median age 5 years, range 0–17; median weight 15.9 kg, range 3.6–91). According to our criteria, 24 (50%) patients developed RVD. TAPSE as the parameter for assessment of longitudinal systolic function was significantly lower in this group (P = 0.01). The difference became even more pronounced after normalization to the RV end-diastolic diameter in long axis with P = 0.003. The odds ratio for patients with TAPSE/RV end-diastolic diameter in long axis P = 0.002). RVD occurs frequently in paediatric patients after left ventricular assist device. TAPSE, normalized to the RV end-diastolic diameter, may help to identify patients at risk for RVD. The predictive value of this parameter supports decision making to plan for adequate pharmacological support or consider early upgrading to mechanical RV support.
- 31 July 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (6) , 887-891
Open AccessIncidence and echocardiographic predictors of early postoperative right ventricular dysfunction following left ventricular assist implantation in paediatric patients
Left ventricular assist device implantation is an established therapy for paediatric patients with end-stage heart failure. Early right ventricular dysfunction (RVD) after implantation still remains a challenge in the postoperative period. This study sought to determine the incidence of RVD and to identify echocardiographic predictors of RVD in paediatric patients, as well describing associated clinical outcome. Prospectively collected preoperative echocardiographic, haemodynamic, demographic and biochemical data from 48 patients scheduled for left ventricular assist device implantation were evaluated. Incidence of high central venous pressure, decreased central venous saturation, high inotropic support requirements or need for mechanical support of the right ventricle during the first 48 h after implantation were used to define RVD. Echocardiographic assessments of right ventricular geometry, function using linear dimensions, areas and tricuspid annular plane systolic excursion (TAPSE) were performed preoperatively and the relative relationships between these parameters were evaluated. We included 48 consecutive paediatric patients (median age 5 years, range 0–17; median weight 15.9 kg, range 3.6–91). According to our criteria, 24 (50%) patients developed RVD. TAPSE as the parameter for assessment of longitudinal systolic function was significantly lower in this group (P = 0.01). The difference became even more pronounced after normalization to the RV end-diastolic diameter in long axis with P = 0.003. The odds ratio for patients with TAPSE/RV end-diastolic diameter in long axis P = 0.002). RVD occurs frequently in paediatric patients after left ventricular assist device. TAPSE, normalized to the RV end-diastolic diameter, may help to identify patients at risk for RVD. The predictive value of this parameter supports decision making to plan for adequate pharmacological support or consider early upgrading to mechanical RV support.
- 31 January 2009
- Published by Springer Nature in Intensive Care Medicine
- Vol. 35 (6) , 1100-1105
Hypercapnia in late-phase ALI/ARDS: providing spontaneous breathing using pumpless extracorporeal lung assist
Objective The fibroproliferative phase of late ALI/ARDS as described by Hudson and Hough (Clin Chest Med 27:671–677, 2006) is associated with pronounced reductions in pulmonary compliance and an accompanying hypercapnia complicating low tidal volume mechanical ventilation. We report the effects of extracorporeal CO2 removal by means of a novel pumpless extracorporeal lung assist (p-ECLA) on tidal volumes, airway pressures, breathing patterns and sedation management in pneumonia patients during late-phase ARDS. Design Retrospective analysis. Setting Fourteen-bed university hospital ICU. Patients Ten consecutive late-phase ALI/ARDS patients with low pulmonary compliance, and severe hypercapnia. Intervention Gas exchange, tidal volumes, airway pressures, breathing patterns and sedation requirements before (baseline) and after (2–4 days) initiation of treatment with p-ECLA were analysed. Patients were ventilated in a pressure-controlled mode with PEEP adjusted to pre-defined oxygenation goals. Measurements and main results Median reduction in pCO2 was 50% following institution of p-ECLA. Extracorporeal CO2 removal enabled significant reduction in tidal volumes (to below 4 ml/kg predicted body weight) and inspiratory plateau pressures [30 (28.5/32.3) cmH2O, median 25, 75% percentiles]. Normalization of pCO2 levels permitted significant reduction in the dosages of analgesics and sedatives. The proportion of assisted spontaneous breathing increased within 24 h of instituting p-ECLA. Conclusion Elimination of CO2 by p-ECLA therapy allowed reduction of ventilator-induced shear stress through ventilation with tidal volumes below 4 ml/kg predicted body weight in pneumonia patients with severely impaired pulmonary compliance during late-phase ARDS. p-ECLA treatment supported control of breathing pattern while sedation requirements were reduced and facilitated the implementation of assisted spontaneous breathing.
- 31 January 2009
- Published by Springer Nature in Intensive Care Medicine
- Vol. 35 (6) , 1100-1105
Hypercapnia in late-phase ALI/ARDS: providing spontaneous breathing using pumpless extracorporeal lung assist
Objective The fibroproliferative phase of late ALI/ARDS as described by Hudson and Hough (Clin Chest Med 27:671–677, 2006) is associated with pronounced reductions in pulmonary compliance and an accompanying hypercapnia complicating low tidal volume mechanical ventilation. We report the effects of extracorporeal CO2 removal by means of a novel pumpless extracorporeal lung assist (p-ECLA) on tidal volumes, airway pressures, breathing patterns and sedation management in pneumonia patients during late-phase ARDS. Design Retrospective analysis. Setting Fourteen-bed university hospital ICU. Patients Ten consecutive late-phase ALI/ARDS patients with low pulmonary compliance, and severe hypercapnia. Intervention Gas exchange, tidal volumes, airway pressures, breathing patterns and sedation requirements before (baseline) and after (2–4 days) initiation of treatment with p-ECLA were analysed. Patients were ventilated in a pressure-controlled mode with PEEP adjusted to pre-defined oxygenation goals. Measurements and main results Median reduction in pCO2 was 50% following institution of p-ECLA. Extracorporeal CO2 removal enabled significant reduction in tidal volumes (to below 4 ml/kg predicted body weight) and inspiratory plateau pressures [30 (28.5/32.3) cmH2O, median 25, 75% percentiles]. Normalization of pCO2 levels permitted significant reduction in the dosages of analgesics and sedatives. The proportion of assisted spontaneous breathing increased within 24 h of instituting p-ECLA. Conclusion Elimination of CO2 by p-ECLA therapy allowed reduction of ventilator-induced shear stress through ventilation with tidal volumes below 4 ml/kg predicted body weight in pneumonia patients with severely impaired pulmonary compliance during late-phase ARDS. p-ECLA treatment supported control of breathing pattern while sedation requirements were reduced and facilitated the implementation of assisted spontaneous breathing.
- 28 November 2008
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 32 (6) , 1652-1655
Bronchial fistulae in ARDS patients: management with an extracorporeal lung assist device
Patients with bronchial tree lesions feature, in particular, a high risk for developing bronchial fistulae after surgical repair when the clinical situation is complicated by acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and mechanical ventilation is needed. The current authors hypothesised that extracorporeal carbon dioxide removal would significantly decrease inspiratory airway pressures, thus promoting the protection of surgical bronchial reconstruction.Four patients were studied after surgical reconstruction of bronchial fistulae in whom ALI/ARDS developed and mechanical ventilation with positive end-expiratory pressure was required. Gas exchange, tidal volumes, airway pressures, respiratory frequency, vasopressor and sedation requirements were analysed before and after initiation of a pumpless extracorporeal lung assist device (pECLA; NovaLung®, Talheim, Germany). Initiation of pECLA treatment enabled a reduction of inspiratory plateau airway pressures from 32.4 to 28.6 cmH2O (3.2 to 2.8 kPa), effectively treated hypercapnia (from 73.6 to 53.4 mmHg (9.8 to 7.1 kPa)) and abolished respiratory acidosis (from pH 7.24 to 7.41). All patients survived and were discharged to rehabilitation clinics.In patients after surgical bronchial reconstruction that was complicated by acute lung injury/acute respiratory distress syndrome, use of pumpless extracorporeal carbon dioxide removal was safe and efficient. Initiation of a pumpless extracorporeal lung assist device enabled a less invasive ventilator management, which may have contributed to healing of surgical bronchial repair.
- 28 November 2008
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 32 (6) , 1652-1655
Bronchial fistulae in ARDS patients: management with an extracorporeal lung assist device
Patients with bronchial tree lesions feature, in particular, a high risk for developing bronchial fistulae after surgical repair when the clinical situation is complicated by acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and mechanical ventilation is needed. The current authors hypothesised that extracorporeal carbon dioxide removal would significantly decrease inspiratory airway pressures, thus promoting the protection of surgical bronchial reconstruction.Four patients were studied after surgical reconstruction of bronchial fistulae in whom ALI/ARDS developed and mechanical ventilation with positive end-expiratory pressure was required. Gas exchange, tidal volumes, airway pressures, respiratory frequency, vasopressor and sedation requirements were analysed before and after initiation of a pumpless extracorporeal lung assist device (pECLA; NovaLung®, Talheim, Germany). Initiation of pECLA treatment enabled a reduction of inspiratory plateau airway pressures from 32.4 to 28.6 cmH2O (3.2 to 2.8 kPa), effectively treated hypercapnia (from 73.6 to 53.4 mmHg (9.8 to 7.1 kPa)) and abolished respiratory acidosis (from pH 7.24 to 7.41). All patients survived and were discharged to rehabilitation clinics.In patients after surgical bronchial reconstruction that was complicated by acute lung injury/acute respiratory distress syndrome, use of pumpless extracorporeal carbon dioxide removal was safe and efficient. Initiation of a pumpless extracorporeal lung assist device enabled a less invasive ventilator management, which may have contributed to healing of surgical bronchial repair.